United Kingdom· GB-APID-31010811000001107
Cresemba 100mg capsules
A isavuconazole product containing isavuconazole, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Isavuconazole is registered in 12 of 19 countries.
Countries holding a registration under ATC J02AC05 (isavuconazole), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Isavuconazole · ATC J02AC05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of isavuconazole costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Isavuconazole · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$134.64
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Isavuconazole
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- J02AC05
- ATC class
- Isavuconazole
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin7640137531171
- gtin7640137530822
- gtin7640137532338
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
265 interactions on record for isavuconazole.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isavuconazole · interactions on record
265 records
- 49 severe
- 207 moderate
- 9 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- EliglustatA16AX10severe
- CilostazolB01AC23severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isavuconazole in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5475ffdd-92c4-418f-aa23-4a656d5eb932 GET /v1/drugs/5475ffdd-92c4-418f-aa23-4a656d5eb932?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "31010811000001107",
"desc": "Cresemba 100mg capsules (Pfizer Ltd)",
"form": "Oral capsule",
"vpid": "31060911000001101",
"source": "dmd",
"vtm_id": "31010011000001101",
"strength": "100 mg",
"substance": "Isavuconazole",
"ingredient": "Isavuconazonium sulfate",
"supplier_code": "2082201000001106"
}See everything about isavuconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.